The systematic review provides a qualitative analysis of whether serum levels of trypsin, trypsinogen-1, trypsinogen-2 and TAP on admission are useful in clinical practice as prognostic markers of the severity of AP. This evidence concerns the gene PRSS1 and alkaline phosphatase measurement.